GT Biopharma, Inc. (GTBP) SEC filings
GTBP SEC filings moved a median of -1.70% by the close. GTBP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the GTBP overview →
87 measured GTBP SEC filing events.
Where these GTBP SEC filings landedvs 87 measured GTBP SEC filing reactions
| Middle 50% of GTBP SEC filing reactions | -7.54% to +1.41% |
|---|---|
| Median reaction (to close) | -1.70% |
| Measured reactions | 87 |
Point-in-time · zero look-ahead
Half of the 87 GTBP SEC filing events with a measured close landed between -7.54% and +1.41%; 39% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form DEF 14A GT Biopharma, Inc. For: Oct 13 | SEC filing · Form DEF | +0.00% | -3.57% | |
| Form S-1 GT Biopharma, Inc. | SEC filing · Form S-1 | -3.98% | +0.15% | |
| Form PRE 14A GT Biopharma, Inc. For: Oct 02 | SEC filing · Form PRE | +0.00% | +0.00% | |
| Form D GT Biopharma, Inc. | SEC filing · Form D | — | +1.40% | |
| Form 8-K GT Biopharma, Inc. For: Sep 22 | SEC filing · Form 8-K | -0.36% | -2.86% | |
| Form 8-K GT Biopharma, Inc. For: Sep 18 | SEC filing · Form 8-K | -1.54% | +0.84% | |
| Form 8-K GT Biopharma, Inc. For: Sep 14 | SEC filing · Form 8-K | -9.71% | -14.12% | |
| Form 8-K GT Biopharma, Inc. For: Sep 02 | SEC filing · Form 8-K | -0.74% | -10.59% | |
| Form 10-Q GT Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.42% | +0.34% | |
| Form 8-K GT Biopharma, Inc. For: Aug 14 | SEC filing · Form 8-K | +1.00% | -1.72% | |
| Form DEF 14A GT Biopharma, Inc. For: Jul 02 | SEC filing · Form DEF | -5.91% | +0.16% | |
| Form PRE 14A GT Biopharma, Inc. For: Jun 18 | SEC filing · Form PRE | +1.85% | -8.35% | |
| Form 8-K GT Biopharma, Inc. For: Jun 08 | SEC filing · Form 8-K | -4.87% | -3.70% | |
| Form 8-K GT Biopharma, Inc. For: May 20 | SEC filing · Form 8-K | -0.86% | +0.00% | |
| Form 10-Q GT Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -10.81% | -12.56% | |
| Form EFFECT GT Biopharma, Inc. | SEC filing · Form EFFECT | +7.67% | +17.35% | |
| Form S-1 GT Biopharma, Inc. | SEC filing · Form S-1 | +2.26% | +4.98% | |
| Form 8-K GT Biopharma, Inc. For: Apr 03 | SEC filing · Form 8-K | -0.35% | +0.02% | |
| Form 10-Q/A GT Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -4.26% | -9.35% | |
| Form 10-Q/A GT Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -4.26% | -9.35% | |
| Form 10-K GT Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.67% | +0.95% | |
| Form 8-K GT Biopharma, Inc. For: Mar 01 | SEC filing · Form 8-K | +0.67% | +0.95% | |
| Form EFFECT GT Biopharma, Inc. | SEC filing · Form EFFECT | -2.14% | -21.49% | |
| Form S-1 GT Biopharma, Inc. | SEC filing · Form S-1 | +1.32% | +2.03% | |
| Form EFFECT GT Biopharma, Inc. | SEC filing · Form EFFECT | -3.65% | -22.05% | |
| Form 8-K GT Biopharma, Inc. For: Nov 20 | SEC filing · Form 8-K | -2.13% | -0.87% | |
| Form 10-Q GT Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -8.36% | -8.97% | |
| Form 8-K GT Biopharma, Inc. For: Nov 14 | SEC filing · Form 8-K | -4.00% | +23.60% | |
| Form S-1 GT Biopharma, Inc. | SEC filing · Form S-1 | -3.85% | -0.52% | |
| Form 8-K GT Biopharma, Inc. For: Sep 25 | SEC filing · Form 8-K | -2.32% | -29.18% | |
| Form 8-K GT Biopharma, Inc. For: Sep 17 | SEC filing · Form 8-K | -2.38% | -4.77% | |
| Form 8-K GT Biopharma, Inc. For: Aug 26 | SEC filing · Form 8-K | -1.07% | -3.31% | |
| Form 10-Q GT Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -10.95% | -8.22% | |
| Form 8-K GT Biopharma, Inc. For: Jul 24 | SEC filing · Form 8-K | -5.41% | -7.21% | |
| Form EFFECT GT Biopharma, Inc. | SEC filing · Form EFFECT | -0.33% | -8.06% | |
| Form S-1/A GT Biopharma, Inc. | SEC filing · Form S-1 | -0.28% | +0.84% | |
| Form 8-K GT Biopharma, Inc. For: Jun 10 | SEC filing · Form 8-K | -0.25% | -9.03% | |
| Form DEF 14A GT Biopharma, Inc. For: Jun 11 | SEC filing · Form DEF | -0.25% | -9.03% | |
| Form DEFA14A GT Biopharma, Inc. | SEC filing · Form DEFA14A | -0.25% | -9.03% | |
| Form S-1 GT Biopharma, Inc. | SEC filing · Form S-1 | -0.25% | -9.03% | |
| Form PRE 14A GT Biopharma, Inc. For: May 30 | SEC filing · Form PRE | +1.69% | +1.50% | |
| Form D GT Biopharma, Inc. | SEC filing · Form D | +0.00% | -6.25% | |
| Form 8-K GT Biopharma, Inc. For: May 21 | SEC filing · Form 8-K | -2.12% | +1.07% | |
| Form D GT Biopharma, Inc. | SEC filing · Form D | -2.12% | +1.07% | |
| Form 10-Q GT Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.90% | +0.90% | |
| Form 8-K GT Biopharma, Inc. For: May 07 | SEC filing · Form 8-K | +0.00% | +1.86% | |
| Form 8-K GT Biopharma, Inc. For: May 12 | SEC filing · Form 8-K | — | -6.16% | |
| Form 8-K GT Biopharma, Inc. For: Apr 29 | SEC filing · Form 8-K | — | +3.93% | |
| Form 10-K/A GT Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | — | +6.28% | |
| Form 8-K GT Biopharma, Inc. For: Mar 31 | SEC filing · Form 8-K | +0.00% | +3.67% | |
| Form EFFECT GT Biopharma, Inc. | SEC filing · Form EFFECT | +0.00% | +3.23% | |
| Form D GT Biopharma, Inc. | SEC filing · Form D | +0.00% | +2.05% | |
| Form S-3 GT Biopharma, Inc. | SEC filing · Form S-3 | +2.15% | +5.17% | |
| Form 8-K GT Biopharma, Inc. For: Feb 25 | SEC filing · Form 8-K | +6.08% | +6.98% | |
| GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement | Press release | +6.09% | +0.00% | |
| Form RW GT Biopharma, Inc. | SEC filing · Form RW | +0.00% | -7.31% | |
| Form 10-K GT Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -7.31% | |
| Form S-1/A GT Biopharma, Inc. | SEC filing · Form S-1 | — | -4.02% | |
| Form 8-K GT Biopharma, Inc. For: Jan 27 | SEC filing · Form 8-K | +0.64% | -13.19% | |
| Form S-1/A GT Biopharma, Inc. | SEC filing · Form S-1 | +0.64% | -13.19% | |
| Form S-1 GT Biopharma, Inc. | SEC filing · Form S-1 | -2.64% | +5.61% | |
| Form 8-K GT Biopharma, Inc. For: Nov 21 | SEC filing · Form 8-K | — | -2.44% | |
| Form 8-K GT Biopharma, Inc. For: Nov 18 | SEC filing · Form 8-K | +0.00% | -5.64% | |
| Form 10-Q GT Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | +4.10% | -0.34% | |
| Form 8-K GT Biopharma, Inc. For: Sep 16 | SEC filing · Form 8-K | +0.00% | +5.63% | |
| Form 10-Q GT Biopharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.61% | +3.04% | |
| Form EFFECT GT Biopharma, Inc. | SEC filing · Form EFFECT | -3.04% | -5.00% | |
| Form 8-K GT Biopharma, Inc. For: Jun 27 | SEC filing · Form 8-K | -10.73% | -11.04% | |
| Form S-1/A GT Biopharma, Inc. | SEC filing · Form S-1 | +0.00% | -6.00% | |
| Form 8-K GT Biopharma, Inc. For: Jun 25 | SEC filing · Form 8-K | -11.20% | -21.01% | |
| Form S-1 GT Biopharma, Inc. | SEC filing · Form S-1 | -0.33% | -5.63% | |
| Form DEFA14A GT Biopharma, Inc. | SEC filing · Form DEFA14A | +1.71% | +2.05% | |
| Form 8-K GT Biopharma, Inc. For: Jun 03 | SEC filing · Form 8-K | +1.62% | -7.77% | |
| Form 8-K GT Biopharma, Inc. For: May 21 | SEC filing · Form 8-K | +0.22% | -13.33% | |
| Form 10-Q GT Biopharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +7.57% | |
| Form 8-K GT Biopharma, Inc. For: Apr 25 | SEC filing · Form 8-K | -0.00% | -0.00% | |
| Form ARS GT Biopharma, Inc. For: Dec 31 | SEC filing · Form ARS | — | -1.96% | |
| Form DEF 14A GT Biopharma, Inc. For: Apr 29 | SEC filing · Form DEF | — | -1.96% | |
| Form DEFA14A GT Biopharma, Inc. | SEC filing · Form DEFA14A | — | -1.96% | |
| Form 10-K GT Biopharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.68% | |
| Form 8-K GT Biopharma, Inc. For: Feb 01 | SEC filing · Form 8-K | +0.28% | +5.87% | |
| Form 8-K GT Biopharma, Inc. For: Dec 18 | SEC filing · Form 8-K | +7.56% | +7.12% | |
| Form 8-K GT Biopharma, Inc. For: Dec 04 | SEC filing · Form 8-K | -0.04% | +1.43% | |
| Form DEF 14A GT Biopharma, Inc. For: Nov 06 | SEC filing · Form DEF | +0.07% | -1.70% | |
| Form DEFA14A GT Biopharma, Inc. | SEC filing · Form DEFA14A | +0.07% | -1.70% | |
| Form 10-Q GT Biopharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +4.17% | |
| Form PRE 14A GT Biopharma, Inc. For: Oct 27 | SEC filing · Form PRE | — | -0.72% |
Keep exploring
More GTBP: earnings → · analyst actions → · GTBP overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| DURECT Corporation (DRRX) | 159 | +0.03% | 51% |
| Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD) | 159 | -1.80% | 36% |
| ImmuCell Corporation (ICCC) | 159 | 0.00% | 42% |
| CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN) | 158 | -1.25% | 25% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.